| |
| |
|
| Insider
Information: |
Lee Yuchun |
| Relationship: |
Director |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,875 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$752,025 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,875 |
|
|
| Total
Value |
$752,025 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Unica Corp |
UNCA |
President, CEO & Chair... |
2010-10-05 |
0 |
2010-10-05 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2023-01-27 |
1,875 |
2015-09-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-27 |
4 |
AS |
$321.31 |
$460,177 |
D/D |
(1,429) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-27 |
4 |
OE |
$72.14 |
$103,088 |
D/D |
1,429 |
3,304 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-26 |
4 |
AS |
$315.42 |
$1,273,322 |
D/D |
(4,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-26 |
4 |
OE |
$72.14 |
$288,560 |
D/D |
4,000 |
5,875 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-25 |
4 |
AS |
$312.80 |
$1,255,852 |
D/D |
(4,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-25 |
4 |
OE |
$72.14 |
$288,560 |
D/D |
4,000 |
5,875 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-24 |
4 |
AS |
$312.29 |
$1,250,753 |
D/D |
(4,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-24 |
4 |
OE |
$72.14 |
$288,560 |
D/D |
4,000 |
5,875 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-23 |
4 |
OE |
$72.14 |
$153,586 |
D/D |
2,129 |
4,004 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-23 |
4 |
AS |
$312.02 |
$664,291 |
D/D |
(2,129) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-18 |
4 |
AS |
$312.17 |
$137,979 |
D/D |
(442) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-18 |
4 |
OE |
$72.14 |
$31,886 |
D/D |
442 |
2,317 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-17 |
4 |
AS |
$312.03 |
$1,248,120 |
D/D |
(4,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2023-01-17 |
4 |
OE |
$72.14 |
$288,560 |
D/D |
4,000 |
5,875 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-18 |
4 |
OE |
$81.54 |
$163,080 |
D/D |
2,000 |
3,875 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-18 |
4 |
AS |
$282.70 |
$568,467 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-14 |
4 |
AS |
$287.87 |
$578,117 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-14 |
4 |
OE |
$81.54 |
$163,080 |
D/D |
2,000 |
3,875 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-13 |
4 |
OE |
$81.54 |
$163,080 |
D/D |
2,000 |
3,875 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-13 |
4 |
AS |
$281.49 |
$575,010 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-12 |
4 |
AS |
$279.22 |
$562,051 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-12 |
4 |
OE |
$81.54 |
$163,080 |
D/D |
2,000 |
3,875 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-11 |
4 |
AS |
$279.81 |
$560,599 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-11 |
4 |
OE |
$81.54 |
$163,080 |
D/D |
2,000 |
3,875 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-08 |
4 |
OE |
$81.54 |
$163,080 |
D/D |
2,000 |
3,875 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
